Stocks and Investing
by (remove) : Do Kim
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Do Kim
RSSJSONXMLCSV
Tue, February 21, 2023
Wed, February 8, 2023
Thu, January 19, 2023
Wed, January 11, 2023
Mon, December 12, 2022
Fri, October 14, 2022
Wed, August 17, 2022
Tue, July 26, 2022
Fri, July 15, 2022
Thu, June 23, 2022
Tue, May 17, 2022
Wed, May 11, 2022
Fri, May 6, 2022
Fri, April 22, 2022
Thu, March 31, 2022
Fri, November 19, 2021
Tue, February 2, 2021
Mon, January 25, 2021
Tue, January 5, 2021
Fri, December 18, 2020
Thu, May 7, 2020
Thu, April 30, 2020
Mon, November 25, 2019

Do Kim Maintained (TVTX) at Buy with Increased Target to $46 on, Feb 21st, 2023


Published on 2024-10-28 01:46:53 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $42 to $46 on, Feb 21st, 2023.

Do has made no other calls on TVTX in the last 4 months.



There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022


This is the rating of the analyst that currently disagrees with Do


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, January 30th, 2023
Contributing Sources